Atlas Trials

A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)

Clinical trial NCT07199465 · RECRUITING

Trial details

NCT number
NCT07199465
Sponsor
Merck Sharp & Dohme LLC
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Cytomegalovirus Prophylaxis
Start date
2026-03-30
Primary completion
2028-04-14
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.